On the contrary, opioid receptors antagonists exhibit a potent inhibition of tumor gross growth and cancer associated pain[9] Therefore, μ‐opioid receptor (MOR) antagonists are a better choice for their positive effects on tumor suppression and pain relief.[10]. The gene discussed is OPRM1; the disease is neoplasm.